Alenson Carman
SEC insider (Form 3/4/5 filer). CIK 0001688865. Officer at Prime Medicine, Inc. (PRME). 10 reported Form 4/5 transactions since Sep 2024; latest on Feb 23, 2026. Located in CAMBRIDGE, MA.
Companies Alenson Carman has filed insider reports for
- Prime Medicine, Inc. (PRME): Officer, See Remarks
Alenson Carman
CIK: 0001688865
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Prime Medicine, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Feb 23, 2026PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
140K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
16.1K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
90.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
90.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
6.3K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
16.1K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
DispositionDirectStock Option (right to buy)
90.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
90.5K shares- - Aug 1, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
6.3K shares- - Feb 27, 2025PRME
Prime Medicine, Inc.
AwardDirectStock Option (right to buy)
90.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 23, 2026 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 140,000 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 16,083 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 90,498 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 90,498 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 6,254 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 16,083 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Disposition Stock Option (right to buy) | 90,498 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 90,498 | - | - | Direct |
| Aug 1, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 6,254 | - | - | Direct |
| Feb 27, 2025 | PRME Prime Medicine, Inc. | Award Stock Option (right to buy) | 90,500 | - | - | Direct |
1-10 of 10 transactions